Enveric Biosciences Identifies Neuroplastogen Candidates for Disease
May 20, 2025
Enveric files provisional patent application on newly identified group of molecules Enveric Biosciences, a biotechnology company dedicated to the development of novel neuroplastogenic small-molecule therapeutics